NCT00312741

Brief Summary

The hypothesis is that community-acquired pneumonia is usually a monomicrobial infection. Therefore, early detection of the etiology allows to select the most active, narrow-spectrum, and cheap, and less toxic antibiotic agent.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2006

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 11, 2006

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

February 27, 2009

Status Verified

February 1, 2009

First QC Date

April 7, 2006

Last Update Submit

February 26, 2009

Conditions

Community-Acquired Pneumonia

Keywords

community-acquired pneumoniamicrobiological testsurinary antigenselection of antibiotic treatment

Outcome Measures

Primary Outcomes (1)

  • Clinical and economic consequences obtained with the antibiotic selection in basis to early mcrobiological results

Secondary Outcomes (2)

  • Importance of polimicrobial etiology in community-acquired pneumonia

  • Practice usefulness of urinary antigen detection tests in pneumonia

Interventions

empirical versus microbiological guided treatmentPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18 years and above
  • Clinical and radiological diagnosis of community-acquired pneumonia
  • Informed consent of patient
  • Hospital admission

You may not qualify if:

  • Prior hospital admission (less than 15 days)
  • Alternative diagnosis at the discharge
  • Immunosuppression (HIV infection, immunosuppressive therapies, neutropenia)
  • Risk factors for unusual etiologies
  • Patient is pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Arnau de Vilanova

Lleida, Lleida, 25198, Spain

RECRUITING

MeSH Terms

Conditions

Community-Acquired Pneumonia

Condition Hierarchy (Ancestors)

Community-Acquired InfectionsInfectionsPneumoniaRespiratory Tract InfectionsRespiratory Tract Diseases

Study Officials

  • Miquel Falguera, M.D.

    Hospital Arnau de Vilanova (Lleida)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Miquel Falguera, M.D.

CONTACT

0034-973248100mfalguera@comll.cat

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 7, 2006

First Posted

April 11, 2006

Study Start

April 1, 2006

Study Completion

May 1, 2008

Last Updated

February 27, 2009

Record last verified: 2009-02

Locations

ES(1)